Atlas Trials

Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML

Clinical trial NCT03709576 · TERMINATED

Trial details

NCT number
NCT03709576
Sponsor
Milton S. Hershey Medical Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia (AML)
Start date
2018-07-18
Primary completion
2019-07-22
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.